Ingevity Corporation
NYSE:NGVT · New York Stock Exchange
+$0.81 today
Vol 0.21M · Avg 0.26M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NYSE:NGVT · Revenue to Net Income
Key Ratios
Analysis
$1.2B of revenue converted into -$127.8M of net income for the selected period. Gross margin is 39.4% and net margin is -9.3%, showing how much revenue survives after costs and taxes. EPS is $-3.55, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B -17.0% | $1.4B -16.9% | $1.7B +1.4% | $1.7B +19.9% | $1.4B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $706.1M -25.8% | $951.7M -22.0% | $1.2B +11.1% | $1.1B +25.0% | $878.7M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $461.5M +1.5% | $454.7M -3.6% | $471.9M -17.2% | $570.1M +11.2% | $512.8M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 39.5% +7.2pp | 32.3% +4.4pp | 27.9% -6.3pp | 34.2% -2.7pp | 36.9% | 9.8% | 28.9% | 38.3% |
| Research & Development | $28.4M +1.1% | $28.1M -11.6% | $31.8M +5.0% | $30.3M +15.2% | $26.3M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $171.2M +2.7% | $166.7M -9.3% | $183.7M -7.6% | $198.8M +10.9% | $179.3M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $199.6M +2.5% | $194.8M -9.6% | $215.5M -5.9% | $229.1M +11.4% | $205.6M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $106.4M -1.8% | $108.3M -11.8% | $122.8M +12.9% | $108.8M -1.0% | $109.9M | $374.2M | $1.2B | $631.8M |
| EBITDA | $37.4M +111.4% | -$329.5M -260.0% | $206.0M -53.2% | $440.2M +35.7% | $324.4M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 3.2% +26.6pp | -23.4% -35.6pp | 12.2% -14.2pp | 26.4% +3.1pp | 23.3% | 5.6% | 46.3% | 42.0% |
| Operating Income | $261.9M +0.8% | $259.9M +1.4% | $256.4M -24.8% | $341.0M +11.0% | $307.2M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 22.4% +4.0pp | 18.5% +3.3pp | 15.2% -5.3pp | 20.4% -1.6pp | 22.1% | 16.6% | 24.1% | 22.0% |
| Interest Income | $4.4M -36.2% | $6.9M +9.5% | $6.3M +8.6% | $5.8M +45.0% | $4.0M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $77.1M -21.2% | $97.8M +4.8% | $93.3M +51.0% | $61.8M +19.5% | $51.7M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$404.0M +49.2% | -$795.5M -198.5% | -$266.5M -273.2% | -$71.4M +50.6% | -$144.4M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$142.1M +73.5% | -$535.6M -5203.0% | -$10.1M -103.7% | $269.6M +65.6% | $162.8M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -12.2% +25.9pp | -38.1% -37.5pp | -0.6% -16.8pp | 16.2% +4.5pp | 11.7% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $8.2M +107.8% | -$105.3M -2140.4% | -$4.7M -108.1% | $58.0M +29.8% | $44.7M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$167.1M +61.2% | -$430.3M -7868.5% | -$5.4M -102.6% | $211.6M +79.2% | $118.1M | $4.9B | $4.8B | $4.7B |
| Net Margin | -14.3% +16.3pp | -30.6% -30.3pp | -0.3% -13.0pp | 12.7% +4.2pp | 8.5% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$5 +61.1% | -$12 -7800.0% | -$0 -102.7% | $6 +86.5% | $3 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$5 +61.1% | -$12 -7800.0% | -$0 -102.7% | $6 +86.4% | $3 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $36.2M -0.3% | $36.3M -0.5% | $36.5M -5.1% | $38.5M -3.3% | $39.8M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $36.2M -0.3% | $36.3M -0.5% | $36.5M -5.1% | $38.5M -4.0% | $40.1M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Elevra Lithium Limited
NASDAQ:ELVR
$6.44B

Skeena Resources Limited
NYSE:SKE
$3.57B

The Chemours Company
NYSE:CC
$3.28B
Allied Gold Corporation
NYSE:AAUC
$3.24B

Ashland Inc.
NYSE:ASH
$3.05B

Quaker Chemical Corporation
NYSE:KWR
$2.60B

Olin Corporation
NYSE:OLN
$2.50B

Minerals Technologies Inc.
NYSE:MTX
$2.41B

Innospec Inc.
NASDAQ:IOSP
$2.05B

FMC Corporation
NYSE:FMC
$1.42B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does NGVT generate?
Ingevity Corporation (NGVT) reported $1.17B of revenue in fiscal 2025.
Is NGVT profitable?
Ingevity Corporation (NGVT) reported -$167,100,000.00 of net income, with a net margin of -14.3%.
Explore More
Continue the stock analysis
Jump to another research area for this company.